INNOVEOX gets Charles Rosier as new Partner and TOTAL EP as first client - Afrik-news.com : Africa news, Maghreb news - The african daily newspaper
In 1991, charles rosier (charles rosier - afrik-news.com) attended his secondary education at Paris’s Fenelon Sainte-Marie. He spent 2 years of extra study in preparation for additional French requirements. He went to Lehman Brothers in 1996 and joined UBS Warburg Investment Bank. At ESCP Europe, Charles Rosier successfully earned his degree, which paved the way to his initial career.
Projects that Promote Culture
Charles Rosier is engaged in philanthropic and cultural activities. This explains the support he gave for a famous French musician and a Silver Lion-winning movie. His love for music and culture paved the way to helping a French female artist. Charles Rosier likes everything about music, particularly singing. He adores French culture, which shows in how much he likes movies.
Charles Rosier: Life Story
He is interested in a lot of things like studies, extreme sports, managing environmentally-friendly activities and culture. In 1996, Charles Rosier started at Lehman Brothers before later becoming a member of UBS Warburg Investment Bank. He then became the head of the finance department at Goldman Sachs Bank. To prepare himself for ESCP Europe, he took additional classes at a private school called Integrale. Charles Rosier developed a partnership with BGT Pactual Bank until 2010.
Environmentally-Friendly Programmes of Charles Rosier
MPOWERD developed economical LED lanterns for poor countries to permit them to get energy solutions in a cost-effective way. Charles Rosier has played a significant role in promoting environmental consciousness and has helped poor countries in developing energy and power sectors. Innoveox is a French company working with the goal of establishing a friendly and pollution-free environment... with Charles Rosier being its dedicated partner.
He helped Baulieu and his colleagues to generate a new drug by financing the research. Being an investor, Charles Rosier receives a profit-share from the company because of his contribution that enabled the company to start doing the study. Mapreg is a pharmaceutical organisation led by Professor Etienne Baulieu. They were invested-in by Charles Rosier when he started to run healthcare projects. Because of the capital he provided, the research on depression, strokes and other serious illnesses was performed at Mapreg, a Paris-based laboratory.
There are around 2,500 employees hired at BTG Pactual, which has 30 years of experience in the market. In 1999, Charles Rosier was offered a job at Goldman Sachs (GMS). After taking the offer, he was appointed as their Managing Director. Charles Rosier managed UBS Warburg’s French-speaking markets of France, Belgium, as well as Quebec.